An Activist Investor Just Bought $1 Billion Worth of Pfizer. Here's What It Means for the Stock
On Oct. 6, The Wall Street Journal reported that activist investor group Starboard Value owns a stake in Pfizer ( PFE -2.82%) that's worth approximately $1 billion. Now, Starboard will aim to work with the company's management as well as consult with former executives -- all with the aim of turning around Pfizer's sagging fortunes.
Pfizer’s Leadership Stability and Activist Investor Watch: A Hold Rating Analysis
Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 7. David
Pfizer: Investor Activism Is Not The Solution
Story of activist fund Starboard Value taking $1B position in Pfizer is grabbing headlines the last few days. Read why I remain bullish on PFE’s long-term growth.
Ex-Pfizer Execs Backed Its Leadership. An Activist Investor Says They Were 'Threatened'
Key Takeaways Two former Pfizer executives published a statement saying they support management as it gets pressured for changes by activist investor Starboard Value.The ex-Pfizer executives, Ian Read and Frank D'Amelio,
Activist investor Starboard cries foul play in exec U-turn at Pfizer
Starboard has accused Pfizer of “coercive conduct” after executives who initially backed the hedge fund retracted their support.
Activist investor may not be able to do much for Pfizer, analyst says
Activist investor Starboard Value's $1 billion stake in Pfizer may not address the company's underlying growth challenges and top-line issues, says
Activist Investor Starboard Value Presses Pfizer's Board Amid Corporate Tensions
The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard pushed Pfizers board to investigate alleged coercive actions. This follows the
Pfizer's CEO gains support of ex-execs amid activist investor talks
Former Pfizer executives who were reportedly working with activist investor Starboard Value days ago to help turnaround the pharma giant have switched sides. Former CEO Ian Read a
3 Reliable Dividend Stocks With Yields Above 5% That You Can Buy With Less Than $100 Right Now
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Business Insider7h
FDA Approves Pfizer's HYMPAVZI For Hemophilia A And B Treatment In Adults And Adolescents
increasing the risk of repeated bleeding inside the joints, which can lead to permanent joint damage. For More Such Health News, visit rttnews.com. Pfizer NewsMORE Related Stocks Indices ...
Pfizer’s stock dips after two former execs say they won’t support Starboard, offer backing for CEO Albert Bourla
Pfizer Inc.’s stock dipped early Thursday after two of its former executives said they would not support an effort by activist shareholder Starboard Value to orchestrate a turnaround. “We have decided ...
These Stocks Moved the Most Today: Pfizer, Super Micro, Generac, Apple, Amazon, Arcadium Lithium, Tesla, Netflix, and More
Activist investor Starboard has taken a $1 billion stake in Pfizer, according to a report, Super Micro stock surges, and ...
Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...
devdiscourse1d
Stocks Slip as Inflation and Jobless Claims Stir Economic Concerns
U.S. stock indexes fell on Thursday amid unexpected inflation and jobless claim figures. The Consumer Price Index increased ...
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Monday. Shares of Pfizer Inc PFE rose during ...
2 Incredibly Cheap Big Pharma Stocks to Buy Now
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.